Acute acetate administration increases endogenous opioid levels in the human brain: A [


Journal

Journal of psychopharmacology (Oxford, England)
ISSN: 1461-7285
Titre abrégé: J Psychopharmacol
Pays: United States
ID NLM: 8907828

Informations de publication

Date de publication:
05 2021
Historique:
pubmed: 8 1 2021
medline: 20 1 2022
entrez: 7 1 2021
Statut: ppublish

Résumé

A recent study has shown that acetate administration leads to a fourfold increase in the transcription of proopiomelanocortin (POMC) mRNA in the hypothalamus. POMC is cleaved to peptides, including β-endorphin, an endogenous opioid (EO) agonist that binds preferentially to the µ-opioid receptor (MOR). We hypothesised that an acetate challenge would increase the levels of EO in the human brain. We have previously demonstrated that increased EO release in the human brain can be detected using positron emission tomography (PET) with the selective MOR radioligand [ Seven volunteers each completed a baseline [ Following sodium acetate administration, 2.5-6.5% reductions in [ We have demonstrated that an acute acetate challenge has the potential to increase EO release in the human brain, providing a plausible mechanism of the central effects of acetate on appetite in humans.

Identifiants

pubmed: 33406950
doi: 10.1177/0269881120965912
pmc: PMC8155733
doi:

Substances chimiques

Analgesics, Opioid 0
Carbon Radioisotopes 0
Opioid Peptides 0
Receptors, Opioid 0
Sodium Acetate 4550K0SC9B
carfentanil LA9DTA2L8F
Fentanyl UF599785JZ

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

606-610

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U120097115
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N00616X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N027078/1
Pays : United Kingdom

Références

J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Eur J Nucl Med Mol Imaging. 2009 Feb;36(2):275-86
pubmed: 18779961
Lancet Diabetes Endocrinol. 2018 Mar;6(3):237-248
pubmed: 28919062
Neurosci Biobehav Rev. 2018 Nov;94:271-285
pubmed: 30071209
Crit Rev Neurobiol. 1997;11(1):35-57
pubmed: 9093813
Curr Top Behav Neurosci. 2012;11:1-24
pubmed: 22016109
Neuroimage. 2009 Jan 1;44(1):252-6
pubmed: 18809501
Neuropsychopharmacology. 2016 Jun;41(7):1742-50
pubmed: 26552847
Mol Psychiatry. 2016 Aug;21(8):1057-62
pubmed: 26460230
Neuroimage. 2011 Jan 1;54(1):264-77
pubmed: 20600980
Mol Psychiatry. 2016 Feb;21(2):243-51
pubmed: 26283642
J Neurosci. 2015 Mar 4;35(9):3959-65
pubmed: 25740524
Mol Psychiatry. 2020 Aug;25(8):1749-1758
pubmed: 29942043
Proc Nutr Soc. 2015 Aug;74(3):328-36
pubmed: 25497601
Nat Commun. 2014 Apr 29;5:3611
pubmed: 24781306
Neuroscience. 1989;33(3):549-57
pubmed: 2636708
JAMA Psychiatry. 2015 Nov;72(11):1087-94
pubmed: 26421634
Nat Rev Neurosci. 2017 Nov 16;18(12):741-752
pubmed: 29142296
Annu Rev Physiol. 2017 Feb 10;79:209-236
pubmed: 28192062
Eur J Neurosci. 2016 May;43(9):1181-9
pubmed: 26790868
Biochem J. 1974 Aug;142(2):401-11
pubmed: 4441381
Sci Transl Med. 2012 Jan 11;4(116):116ra6
pubmed: 22238334
J Neurosci. 2017 Aug 23;37(34):8284-8291
pubmed: 28747384
Psychiatry Res Neuroimaging. 2018 Jun 30;276:41-45
pubmed: 29655552
Biol Psychiatry. 2012 Sep 1;72(5):371-7
pubmed: 22386378
Cell Mol Neurobiol. 2008 Jun;28(4):469-78
pubmed: 18027085
Brain Imaging Behav. 2018 Dec;12(6):1544-1555
pubmed: 29318488
Mol Psychiatry. 2015 Apr;20(4):416-23
pubmed: 25510510
Neuroreport. 2001 Nov 16;12(16):3549-52
pubmed: 11733709
Mol Psychiatry. 2015 Feb;20(2):193-200
pubmed: 25600108
Am J Clin Nutr. 1990 Jan;51(1):112-8
pubmed: 2153334
Nutr Metab (Lond). 2007 Sep 01;4:18
pubmed: 17764572
Neuroimage. 2013 Jan 1;64:277-83
pubmed: 22947541
Pharmacol Biochem Behav. 1983 Mar;18(3):443-7
pubmed: 6132412
Nat Commun. 2019 Oct 3;10(1):4493
pubmed: 31582737
Alcohol Clin Exp Res. 1985 Sep-Oct;9(5):468-71
pubmed: 3904514
Can J Physiol Pharmacol. 1988 Jan;66(1):1-9
pubmed: 3285979
Annu Rev Nutr. 2017 Aug 21;37:183-205
pubmed: 28564556
Am J Clin Nutr. 1972 Aug;25(8):773-9
pubmed: 4558368
Neuroimage. 1996 Dec;4(3 Pt 1):153-8
pubmed: 9345505

Auteurs

Abhishekh H Ashok (AH)

Psychiatric Imaging Group, MRC London Institute of Medical Sciences (LMS), Imperial College London, London, UK.
Psychiatric Imaging Group, Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, UK.
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Department of Radiology, University of Cambridge, Cambridge, UK.
Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Jim Myers (J)

Imperial College London, UK.

Gary Frost (G)

Imperial College London, UK.

Samuel Turton (S)

Imperial College London, UK.
Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK.

Roger N Gunn (RN)

Imperial College London, UK.
Invicro, London, UK.

Jan Passchier (J)

Invicro, London, UK.

Alessandro Colasanti (A)

Department of Neuroscience, Brighton and Sussex Medical School, University of Sussex, Brighton, UK.

Tiago Reis Marques (TR)

Psychiatric Imaging Group, MRC London Institute of Medical Sciences (LMS), Imperial College London, London, UK.
Psychiatric Imaging Group, Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, UK.
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

David Nutt (D)

Imperial College London, UK.

Anne Lingford-Hughes (A)

Imperial College London, UK.

Oliver D Howes (OD)

Psychiatric Imaging Group, MRC London Institute of Medical Sciences (LMS), Imperial College London, London, UK.
Psychiatric Imaging Group, Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, UK.
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Eugenii A Rabiner (EA)

Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK.
Invicro, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH